DocDollars

Mirum Pharmaceuticals, Inc.

CA · United States · Reporting entity ID 100001156888

Total reported 2019–2025
$9.30M
#511 of 2,960 reporting companies — 0% of all reported industry payments
$4.19M in general payments across 8,839 records, plus $5.10M in research funding across 988 records.

How it breaks down

General payments $4,192,888
Research funding $5,102,929

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Mirum Pharmaceuticals, Inc. reported $9.30M to US doctors and teaching hospitals from 2019 to 2025, ranking #511 of 2,960 reporting companies. 55% of that was research funding and 45% general payments such as consulting, speaking, food and travel. 8,839 general payment records and 988 research records were filed.

Common questions about Mirum Pharmaceuticals, Inc.

How much has Mirum Pharmaceuticals, Inc. paid US doctors?

Mirum Pharmaceuticals, Inc. reported $9,295,817 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,192,888 in general payments, $5,102,929 in research funding.

How does Mirum Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #511 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Mirum Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.